Aurora Cannabis Inc
TSX:ACB

Watchlist Manager
Aurora Cannabis Inc Logo
Aurora Cannabis Inc
TSX:ACB
Watchlist
Price: 6.05 CAD 0.5% Market Closed
Market Cap: 332m CAD
Have any thoughts about
Aurora Cannabis Inc?
Write Note

Relative Value

The Relative Value of one ACB stock under the Base Case scenario is 7.69 CAD. Compared to the current market price of 6.05 CAD, Aurora Cannabis Inc is Undervalued by 21%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACB Relative Value
Base Case
7.69 CAD
Undervaluation 21%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
59
Median 3Y
16.5
Median 5Y
26.5
Industry
2.5
Forward
1.1
vs History
vs Industry
Median 3Y
-4.8
Median 5Y
-8.9
Industry
21.9
Forward
-11
vs History
vs Industry
Median 3Y
-21.9
Median 5Y
-46.2
Industry
16.5
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-16
Industry
23.6
vs History
80
vs Industry
66
Median 3Y
4.7
Median 5Y
6.9
Industry
2.1
vs History
80
vs Industry
62
Median 3Y
15.6
Median 5Y
27.1
Industry
2.6
Forward
0.9
vs History
vs Industry
26
Median 3Y
-58.1
Median 5Y
-70
Industry
5.2
vs History
vs Industry
55
Median 3Y
-14.6
Median 5Y
-22.5
Industry
13.3
Forward
9.7
vs History
vs Industry
53
Median 3Y
-11.4
Median 5Y
-17.2
Industry
16.6
Forward
-22.6
vs History
vs Industry
54
Median 3Y
-20.7
Median 5Y
-46.3
Industry
15.6
vs History
vs Industry
42
Median 3Y
-19.4
Median 5Y
-27.3
Industry
19.1
vs History
80
vs Industry
73
Median 3Y
3.9
Median 5Y
5.5
Industry
1.9

Multiples Across Competitors

ACB Competitors Multiples
Aurora Cannabis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Aurora Cannabis Inc
TSX:ACB
331.9m CAD 1.1 -7.6 -2 -1.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
CA
Aurora Cannabis Inc
TSX:ACB
Average P/E: 32.4
Negative Multiple: -7.6
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top